- Home
- NATR vs IMRX Comparison
NATR vs IMRX Comparison
Compare NATR & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NATR
- IMRX
- Stock Information
- Founded
- NATR 1972
- IMRX 2008
- Country
- NATR United States
- IMRX United States
- Employees
- NATR N/A
- IMRX N/A
- Industry
- NATR Biotechnology: Pharmaceutical Preparations
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- NATR Health Care
- IMRX Health Care
- Exchange
- NATR Nasdaq
- IMRX Nasdaq
- Market Cap
- NATR 237.7M
- IMRX 232.9M
- IPO Year
- NATR N/A
- IMRX 2021
- Fundamental
- Price
- NATR $13.75
- IMRX $6.38
- Analyst Decision
- NATR Strong Buy
- IMRX Strong Buy
- Analyst Count
- NATR 2
- IMRX 5
- Target Price
- NATR $20.50
- IMRX $17.20
- AVG Volume (30 Days)
- NATR 66.3K
- IMRX 1.3M
- Earning Date
- NATR 11-06-2025
- IMRX 11-10-2025
- Dividend Yield
- NATR N/A
- IMRX N/A
- EPS Growth
- NATR N/A
- IMRX N/A
- EPS
- NATR 0.75
- IMRX N/A
- Revenue
- NATR $460,818,000.00
- IMRX N/A
- Revenue This Year
- NATR $4.88
- IMRX N/A
- Revenue Next Year
- NATR $2.66
- IMRX N/A
- P/E Ratio
- NATR $18.37
- IMRX N/A
- Revenue Growth
- NATR 4.33
- IMRX N/A
- 52 Week Low
- NATR $11.01
- IMRX $1.10
- 52 Week High
- NATR $18.06
- IMRX $10.08
- Technical
- Relative Strength Index (RSI)
- NATR 37.57
- IMRX 51.51
- Support Level
- NATR $12.97
- IMRX $6.10
- Resistance Level
- NATR $13.99
- IMRX $7.15
- Average True Range (ATR)
- NATR 0.42
- IMRX 0.50
- MACD
- NATR 0.01
- IMRX 0.08
- Stochastic Oscillator
- NATR 42.30
- IMRX 59.90
About NATR Nature's Sunshine Products Inc.
Natures Sunshine Products Inc is a natural health and wellness company, predominantly engaged in the manufacturing and selling of nutritional and personal care products. It offers products related to Weight management, General health, Cardiovascular, Digestive, Immune, and Personal care. The company operates in four segments namely, Asia which is also its key revenue generating market, Europe, North America, Latin America, and Other.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.